The Effect of Allograft Transplantation of Sertoli Cell on Expression of NF-кB, Bax Proteins, and Ischemic Tolerance in Rats with Focal Cerebral Ischemia

Document Type : Research article

Authors

1 Department of Physiology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.

2 Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.

3 Department of Plant Sciences, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.

4 Department of Anatomy and Cell Biology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

One of the newest methods to reduce cerebral ischemia damages is cell therapy. The aim of this study is to evaluate the effect of Sertoli cell transplantation on ischemia-induced injuries in animal models of stroke. Rats were divided into four groups: transplant+ischemia, ischemia, sham, and control. Sertoli cells were separated from the other testis of rats and cultured. Unilateral Sertoli cell transplantation was performed in the right striatum by using stereotaxic surgery. For induction of brain ischemia, middle cerebral artery occlusion surgery was used 14 days after transplantation. By using western blotting method, expression of nuclear factor kappa (NF-кB) and Bax were evaluated. In this study, a remarkable decrease in neurological deficits, infection, blood-brain barrier permeability, and brain edema was observed in the cell transplant recipient group in comparison with the ischemia group. Probably, a reduction in inflammation (NF-кB factor) and apoptosis (Bax) following injection of Sertoli cells result in amelioration of ischemic damages induced by MCAO surgery.

Graphical Abstract

The Effect of Allograft Transplantation of Sertoli Cell on Expression of NF-кB, Bax Proteins, and Ischemic Tolerance in Rats with Focal Cerebral Ischemia

Keywords


  1. Czerny M, Schoenhoff F, Etz C, Englberger L, Khaladj N, Zierer A, Weigang E, Hoffmann I, Blettner M, Carrel TP. The impact of pre-operative malperfusion on outcome in acute type A aortic dissection: results from the GERAADA registry. Journal of the American College of Cardiology. (2015) 65: 2628-2635.
  2. Morimoto N, Okada K, Okita Y. Lack of neurologic improvement after aortic repair for acute type A aortic dissection complicated by cerebral malperfusion: predictors and association with survival. The Journal of thoracic and cardiovascular surgery. (2011) 142: 1540-1544.
  3. Daneshfard B, Izadi S, Shariat A, Toudaji MA, Beyzavi Z, Niknam L. Epidemiology of stroke in Shiraz, Iran. Iranian journal of neurology. (2015) 14: 158.
  4. Asahi M, Wang X, Mori T, Sumii T, Jung J-C, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. Journal of Neuroscience. (2001) 21: 7724-7732.
  5. Haley MJ, Lawrence CB. The blood–brain barrier after stroke: Structural studies and the role of transcytotic vesicles. Journal of Cerebral Blood Flow & Metabolism. (2017) 37: 456-470.
  6. Hossmann K-A. Pathophysiology and therapy of experimental stroke. Cellular and molecular neurobiology. (2006) 26: 1055-1081.
  7. Ortuño-Sahagún D. Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction. Oxidative Medicine and Cellular Longevity. (2013) 2013:
  8. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. The EMBO journal. (1998) 17: 3878-3885.
  9. Liu H-W, Kuang Y-J, Wu J-C, Ma K-H, Wang S-D, Liu J-C. Intrastriatal transplantation of Sertoli cells may improve amphetamine-induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats. Brain research. (1999) 838: 227-233.
  10. Willing AE, Cameron DF, Sanberg PR. Sertoli cell transplants: their use in the treatment of neurodegenerative disease. Molecular medicine today. (1998) 4: 471-477.
  11. Hemendinger R, Wang J, Malik S, Persinski R, Copeland J, Emerich D, Gores P, Halberstadt C, Rosenfeld J. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Experimental neurology. (2005) 196: 235-243.
  12. Bauché F, Fouchard M-H, Jégou B. Antioxidant system in rat testicular cells. FEBS letters. (1994) 349: 392-396.
  13. Mruk DD, Silvestrini B, Mo M-y, Cheng CY. Antioxidant superoxide dismutase-a review: its function, regulation in the testis, and role in male fertility. Contraception. (2002) 65: 305-311.
  14. Kyrönlahti A, Euler R, Bielinska M, Schoeller EL, Moley KH, Toppari J, Heikinheimo M, Wilson DB. GATA4 regulates Sertoli cell function and fertility in adult male mice. Molecular and cellular endocrinology. (2011) 333: 85-95.
  15. Beretta S, Cunningham KM, Haus DL, Gold EM, Perez H, López-Velázquez L, Cummings BJ. Effects of human ES-derived neural stem cell transplantation and kindling in a rat model of traumatic brain injury. Cell transplantation. (2017) 26: 1247-1261.
  16. Mendez I, Hong M, Smith S, Dagher A, Desrosiers J. Neural transplantation cannula and microinjector system: experimental and clinical experience. Journal of neurosurgery. (2000) 92: 493-499.
  17. Güzel A, Nikkhah G, Maciaczyk J, Rölz R, Kahlert UD. A microsurgical procedure for middle cerebral artery occlusion by intraluminal monofilament insertion technique in the rat: a special emphasis on the methodology. Experimental & translational stroke medicine. (2014) 6: 6.
  18. Long J, Cai L, Li J, Zhang L, Yang H, Wang T. JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury. Neural regeneration research. (2013) 8: 1491.
  19. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. Journal of Cerebral Blood Flow & Metabolism. (1990) 10: 290-293.
  20. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain research. (2007) 1152: 228-233.
  21. Fernández-López D, Faustino J, Daneman R, Zhou L, Lee SY, Derugin N, Wendland MF, Vexler ZS. Blood–brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. Journal of Neuroscience. (2012) 32: 9588-9600.
  22. Schäbitz W-R, Hoffmann TT, Heiland S, Kollmar R, Bardutzky J, Sommer C, Schwab S. Delayed neuroprotective effect of insulin-like growth factor-I after experimental transient focal cerebral ischemia monitored with MRI. Stroke. (2001) 32: 1226-1233.
  23. Chen B, Gao X-Q, Yang C-X, Tan S-K, Sun Z-L, Yan N-H, Pang Y-G, Yuan M, Chen G-J, Xu G-T. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain research. (2009) 1284: 1-11.
  24. Ikeda N, Nonoguchi N, Zhao MZ, Watanabe T, Kajimoto Y, Furutama D, Kimura F, Dezawa M, Coffin RS, Otsuki Y. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke. (2005) 36: 2725-2730.
  25. Kilic Ü, Kilic E, Dietz GP, Bähr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke. (2003) 34: 1304-1310.
  26. Wang Y, Kilic E, Kilic Ü, Weber B, Bassetti CL, Marti HH, Hermann DM. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain. (2004) 128: 52-63.
  27. Ma M, Ma Y, Yi X, Guo R, Zhu W, Fan X, Xu G, Frey WH, Liu X. Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone. BMC neuroscience. (2008) 9: 117.
  28. Justicia C, Pérez-Asensio FJ, Burguete MC, Salom JB, Planas AM. Administration of transforming growth factor-α reduces infarct volume after transient focal cerebral ischemia in the rat. Journal of Cerebral Blood Flow & Metabolism. (2001) 21: 1097-1104.
  29. FLANDERS KC, REN RF, LIPPA CF. Transforming growth factor-βs in neurodegenerative disease. Progress in neurobiology. (1998) 54: 71-85.
  30. Kitagawa H, Hayashi T, Mitsumoto Y, Koga N, Itoyama Y, Abe K. Reduction of ischemic brain injury by topical application of glial cell line–derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke. (1998) 29: 1417-1422.
  31. Ay I, Sugimori H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Molecular brain research. (2001) 87: 71-80.
  32. Matsuoka N, Nozaki K, Takagi Y, Nishimura M, Hayashi J, Miyatake S-I, Hashimoto N. Adenovirus-mediated gene transfer of fibroblast growth factor-2 increases BrdU-positive cells after forebrain ischemia in gerbils. Stroke. (2003) 34: 1519-1525.
  33. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA. Basic fibroblast growth factor dilates rat pial arterioles. Journal of Cerebral Blood Flow & Metabolism. (1994) 14: 70-74.
  34. Li Y, Chopp M, Jiang N, Zhang ZG, Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke. (1995) 26: 1252-1258.
  35. Liu X, Zhu X-Z. Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor. Molecular brain research. (1999) 71: 210-216.
  36. Tamatani M, Ogawa S, Nuñez G, Tohyama M. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death & Differentiation. (1998) 5:
  37. Wang Y, Lin S-Z, Chiou A-L, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. Journal of Neuroscience. (1997) 17: 4341-4348.
  38. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends in neurosciences. (1999) 22: 391-397.
  39. Harukuni I, Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurologic clinics. (2006) 24: 1-21.
  40. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. (2007) 38: 674-676.
  41. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? The Journal of laboratory and clinical medicine. (1992) 119: 598-620.
  42. Rosenberg G, Estrada E, Dencoff J. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. (1998) 29: 2189-2195.
  43. Milanizadeh S, Zuwarali KNN, Aliaghaei A, Bigdeli MR. Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses. Journal of Molecular Neuroscience. (2018) 1-10.
  44. Riahy S, Mohammadi MT, Sobhani V. Role of oxygen and nitrogen free radicals in diabetes-induced atherosclerosis and effects of exercise on it. Physiology and Pharmacology. (2014) 18: 1-15.
  45. Obrenovitch T, Richards D. Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovascular and brain metabolism reviews. (1995) 7: 1-54.
  46. Ma³ek R, Borowicz KK, Jargie³³o Mg, Czuczwar SaJ. Role of nuclear factor kB in the central nervous system. Pharmacological Reports. (2007) 59: 25-33.
  47. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. Journal of Applied Physiology. (1994) 76: 5-13.
  48. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. (1996) 12: 274-277.
  49. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proceedings of the National Academy of Sciences. (1994) 91: 1672-1676.
  50. Nie Z, Mei Y, Ford M, Rybak L, Marcuzzi A, Ren H, Stiles GL, Ramkumar V. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor κB. Molecular Pharmacology. (1998) 53: 663-669.
  51. Ramkumar V, Nie Z, Rybak LP, Maggirwar SB. Adenosine, antioxidant enzymes and cytoprotection. Trends in Pharmacological Sciences. (1995) 16: 283-285.
  52. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. Journal of Investigative Surgery. (2005) 18: 335-350.
  53. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. The American journal of pathology. (1997) 151: 1775.
  54. Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PloS one. (2007) 2: e156.
  55. Schäbitz W-R, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke. (2000) 31: 2212-2217.
  56. Friguls B, Justicia C, Pallàs M, Planas AM. Focal cerebral ischemia causes two temporal waves of Akt activation. Neuroreport. (2001) 12: 3381-3384.
  57. Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine & growth factor reviews. (2006) 17: 305-323.
  58. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. Journal of Biological Chemistry. (1997) 272: 12181-12188.
  59. Aliaghaei A, Meymand AZ, Boroujeni ME, Khodagoli F, Meftahi GH, Hadipour MM, Abdollahifar MA, Mesgar S, Ahmadi H, Danyali S. Neuro-Restorative Effect of Sertoli Cell Transplants in a Rat Model of Amyloid Beta Toxicity. Behavioural brain research. (2019)
  60. Anway MD, Folmer J, Wright WW, Zirkin BR. Isolation of Sertoli cells from adult rat testes: an approach to ex vivo studies of Sertoli cell function. Biology of Reproduction. (2003) 68: 996-1002.
  61. Wagle J, Heindel J, Steinberger A, Sanborn B. Effect of hypotonic treatment on Sertoli cell purity and function in culture. In vitro cellular & developmental biology. (1986) 22: 325-331.
  62. Hasegawa K, Saga Y. Retinoic acid signaling in Sertoli cells regulates organization of the blood-testis barrier through cyclical changes in gene expression. Development. (2012) 139: 4347-4355.
  63. Lakpour MR, Aghajanpour S, Koruji M, Shahverdi A, Sadighi-Gilani MA, Sabbaghian M, Aflatoonian R, Rajabian-Naghandar M. Isolation, culture and characterization of human sertoli cells by flow cytometry: Development of procedure. Journal of reproduction & infertility. (2017) 18: 213.
  64. Rodriguez AI, Willing AE, Saporta S, Cameron DF, Sanberg PR. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. Neurotoxicity research. (2003) 5: 443-450.
  65. Borlongan CV, Cameron DF, Saporta S, Sanberg PR. Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Experimental neurology. (1997) 148: 388-392.